Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Cytochrome P-450 aromatase is responsible for catalysing the conversion of androstendione into estrone, so its expression in endometriotic tissue could contribute to the development of endometriosis. The aims of this study were, on the one hand, to determine the presence of aromatase in eutopic and ectopic endometrium, healthy peritoneum, myometrium and leiomyomas from patients with (n = 61) and without endometriosis (n = 12) and, on the other hand, to determine the effect of peritoneal fluid (PF), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNFalpha) on aromatase activity from endometriotic stromal cells and subcutaneous adipocytes. After immunohistochemical analysis, aromatase expression was detected in the endometriotic tissue of 61% of patients, whereas the rest of the tissues, as well as those from disease-free women, were negative. Cell cultures were made to determine aromatase activity in endometriotic stromal cells and adipocytes. The addition of PF, TNFalpha and especially IL-6 (P < 0.05) stimulated the basal enzymatic activity observed in both cell types. Our findings confirm the presence of aromatase in endometriosis and probably the existence of a local estrogen production that may be stimulated by some factors such as cytokines present in the PF of these patients. Therefore, the use of aromatase inhibitors combined with immunomodulator agents could be a novel approach to be investigated in future clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aromatase is expressed by endometriotic lesions and in the eutopic endometrium of women with endometriosis causing a local secretion of estrogens, which promote the growth and invasion of endometriotic lesions and favour the onset of pain and prostaglandin-mediated inflammation (Fig. 4) [275].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [275]
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857 · cited 1×
“Although the aetiology of the disease is not well established, several immunological and biochemical alterations are present in these patients (Bulun et al., 1999; Lebovic et al., 2001).”
BackgroundAromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 4×
“, 1997, 1999) and myometrium (Bulun et al., 1994; Noble et al., 1996) of disease-free women.”
BackgroundResultInfluentialZeitoun, K., Takayama, K., Sasano, H., Suzuki, T., Moghrabi, N., Andersson, S., Johns, A., Meng, L., Putman, M., Carr, B., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5301 · Cited by 308 · cited 2×
“Endometriosis is also a local pelvic inflammatory process, with an altered function of peritoneal immune-related cells unable to eliminate the ectopic tissue ( Wilson et al., 1994 ).”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up
Waller, K. G., & Shaw, R. W. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55791-4 · Cited by 252
[45] Assay of aromatase activity
Lephart, E. D., & Simpson, E. R. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)06116-k · Cited by 242
Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis
Halme, J., Becker, S., & Wing, R. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80037-x · Cited by 232
Cited by
Pathogenesis and pathophysiology of endometriosis
Burney, R. O., & Giudice, L. C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.06.029 · Cited by 1,590
“significantly stimulate aromatase expression in cultured endometriotic stromal cells (90).”
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
GnRH and GnRH receptors in the pathophysiology of the human female reproductive system
Maggi, R., Cariboni, A. M., Marelli, M. M., Moretti, R. M., Andrè, V., Marzagalli, M., & Limonta, P. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv059 · Cited by 269
“…produced estrogens promote the growth and invasion of endometrial lesions and favour the onset of pain and prostaglandin-mediated inflammation (Velasco et al., 2006), and may be responsible for the progression of endometriosis during medical suppression of ovarian function (Bulun et al.,…”
BackgroundBiomarkers in endometriosis: Challenges and opportunities
Ahn, S. H., Singh, V., & Tayade, C. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.009 · Cited by 242
Endometrial alterations in endometriosis: a systematic review of putative biomarkers
May, K. E., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr013 · Cited by 237
“However, three papers report no detectable aromatase expression in the endometrium of patients or controls (Velasco et al., 2006; Colette et al., 2009; Delvoux et al., 2009), and one further paper found no difference in expression between infertile women with and without endometriosis (Morsch et…”
BackgroundRegulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis
García-Gómez, E., Vázquez-Martínez, E. R., Reyes-Mayoral, C., Cruz-Orozco, O. P., Camacho-Arroyo, I., & Cerbón, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00935 · Cited by 195
“Additionally, this pro-inflammatory cytokine participates in the stimulation of aromatase expression in stromal cells from lesions (89), which shows again an interaction between the endocrine system and inflammation processes.”
BackgroundEndometriosis: A Disease That Remains Enigmatic
Acién, P., & Velasco, I. (2013) · ISRN Obstetrics and Gynecology · doi:10.1155/2013/242149 · Cited by 178
“We reported the presence of aromatase in the ectopic endometrium in 70% of the patients, whereas aromatase was absent in the eutopic endometrium [31].”
BackgroundInfluentialSelf-citationEndometrial biomarkers for the non-invasive diagnosis of endometriosis
Gupta, D., Hull, M. L., Fraser, I., Miller, L., Bossuyt, P. M., Johnson, N., & Nisenblat, V. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012165 · Cited by 169
Hung, S. W., Zhang, R., Tan, Z., Chung, J. P. W., Zhang, T., & Wang, C. C. (2021) · Medicinal Research Reviews · doi:10.1002/med.21802 · Cited by 167
Aghajanova, L., Hamilton, A., Kwintkiewicz, J., Vo, K. C., & Giudice, L. C. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.070300 · Cited by 168
Progesterone Resistance in Endometriosis: an Acquired Property?
McKinnon, B., Mueller, M., & Montgomery, G. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.05.006 · Cited by 149
Estrogen metabolizing enzymes in endometrium and endometriosis
Dassen, H., Punyadeera, C., Kamps, R., Delvoux, B., Van Langendonckt, A., Donnez, J., Husen, B., Thole, H., Dunselman, G., & Groothuis, P. (2007) · Human Reproduction · doi:10.1093/humrep/dem310 · Cited by 141
“…transcript level (Noble et al., 1996; Bulun et al., 1997; Matsuzaki et al., 2006; Smuc et al., 2007), at the protein level (Kitawaki et al., 1997,1999; Murakami et al., 2006; Velasco et al., 2006), as well as at the activity level (Kitawaki et al., 1997; Noble et al., 1997; Murakami et al., 2006).”
BackgroundMacrophages and nerve fibres in peritoneal endometriosis
Tran, L. V. P., Tokushige, N., Berbic, M., Markham, R., & Fraser, I. S. (2008) · Human Reproduction · doi:10.1093/humrep/den483 · Cited by 138
“of endometriotic lesions (Velasco et al., 2006).”
Ferrero, S., Camerini, G., Seracchioli, R., Ragni, N., Venturini, P. L., & Remorgida, V. (2009) · Human Reproduction · doi:10.1093/humrep/dep302 · Cited by 134
“Since the late 1990s, several studies using either PCR or immunohistochemistry demonstrated the expression of aromatase P450 in both eutopic and ectopic endometrium from patients with endometriosis, but not in eutopic endometrium from disease-free women and in endometriosis-free peritoneal tissue (Noble et al., 1996;…”
BackgroundSystematic review of the effects of aromatase inhibitors on pain associated with endometriosis
Patwardhan, S., Nawathe, A., Yates, D., Harrison, G., & Khan, K. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01740.x · Cited by 116
Hormonal therapy of endometrial stromal sarcoma
Reich, O., & Regauer, S. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3281a7ef3a · Cited by 113
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review
Ferrero, S., Gillott, D. J., Venturini, P. L., & Remorgida, V. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-89 · Cited by 109
“Since the late 1990s, several independent studies based either on polymerase chain reaction or immunohistochemistry have demonstrated that aromatase P450 is over-expressed in both eutopic and ectopic endometrium of patients with endometriosis, while this enzyme is not detectable in eutopic endometrium obtained from he…”
BackgroundEstrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107
Velasco, I., Acién, P., Campos, A., Acién, M., & Ruiz-Maciá, E. (2010) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.11.004 · Cited by 108
Self-citationMedical Treatments for Endometriosis-Associated Pelvic Pain
Zito, G., Luppi, S., Giolo, E., Martinelli, M., Venturin, I., Di Lorenzo, G., & Ricci, G. (2014) · BioMed Research International · doi:10.1155/2014/191967 · Cited by 93
“The estrogens produced in the endometrial tissue through aromatase promote the growth and invasion of endometrial lesion and favour the onset of pain and prostaglandin-mediated inflammation [59].”
BackgroundFan, Y., Chen, H., Chen, W., Liu, Y., Fu, Y., & Wang, L. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1409717 · Cited by 100
Absence of aromatase protein and mRNA expression in endometriosis
Colette, S., Lousse, J. C., Defrere, S., Curaba, M., Heilier, J. F., Van Langendonckt, A., Mestdagt, M., Foidart, J. M., Loumaye, E., & Donnez, J. (2009) · Human Reproduction · doi:10.1093/humrep/dep199 · Cited by 88
“…(Kitawaki et al., 1997; Noble et al., 1997; Murakami et al., 2006; Purohit et al., 2007) and protein level (Kitawaki et al., 1997, 1999a, b; Ishihara et al., 2003; Wölfler et al., 2005; Murakami et al., 2006; Velasco et al., 2006; Acien et al., 2007; Bukulmez et al., 2007; Hudelist et al., 2007).”
BackgroundMethodResultInfluentialHormone therapy for endometriosis and surgical menopause
Al Kadri, H., Hassan, S., Al-Fozan, H. M., & Hajeer, A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005997.pub2 · Cited by 85
Aromatase and endometriosis: estrogens play a role
Ferrero, S., Remorgida, V., Maganza, C., Venturini, P. L., Salvatore, S., Papaleo, E., Candiani, M., & Leone Roberti Maggiore, U. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12411 · Cited by 85
The Expression and Ovarian Steroid Regulation of Endometrial Micro-RNAs
Toloubeydokhti, T., Pan, Q., Luo, X., Bukulmez, O., & Chegini, N. (2008) · Reproductive Sciences · doi:10.1177/1933719108324132 · Cited by 83
“We also found an elevated expression of CYP19A1, StAR, and COX-2 in EC as compared to EU and EN; however, their expression in EN compared to EU contrasted from previously reported studies.(5,8,10,11,18,47,48) The most likely explanation for the difference could be the method of detection and primers used in these as c…”
ResultRetractedLépine, J., Audet-Walsh, E., Grégoire, J., Têtu, B., Plante, M., Ménard, V., Ayotte, P., Brisson, J., Caron, P., Villeneuve, L., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2648 · Cited by 75
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis
Clemenza, S., Sorbi, F., Noci, I., Capezzuoli, T., Turrini, I., Carriero, C., Buffi, N., Fambrini, M., & Petraglia, F. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.021 · Cited by 63
Konings, G. F. J., Brentjens, L. S., Delvoux, B., Linnanen, T., Cornel, K. M. C., Koskimies, P., Bongers, M. Y., Kruitwagen, R. F. P. M., Xanthoulea, S., & Romano, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00940 · Cited by 74
Aromatase Inhibitors in the Treatment of Severe Endometriosis
Mousa, N. A., Bedaiwy, M. A., & Casper, R. F. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000265807.19397.6d · Cited by 64
New trends for the medical treatment of endometriosis
Rocha, A. L. L., Reis, F. M., & Petraglia, F. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.683783 · Cited by 60
“Aromatase P450 is overexpressed in both eutopic and ectopic endometrium of patients with endometriosis [24-31].”
BackgroundEndometriosis in menopause: a single institution experience
Morotti, M., Remorgida, V., Venturini, P. L., & Ferrero, S. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2473-5 · Cited by 58
The emerging use of aromatase inhibitors for endometriosis treatment
Nothnick, W. B. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-87 · Cited by 55
“Since this initial report, numerous independent investigators have described the expression and cellular localization of aromatase transcript and protein in endometriotic tissue [ 2-8 ] as well as eutopic endometrium from women with the disease [2,3,5,8-13].”
BackgroundMaia, H., Haddad, C., Coelho, G., & Casoy, J. (2012) · Women's Health · doi:10.2217/whe.12.52 · Cited by 52
“In the endometriotic lesions, the severity of the disease also showed a positive correlation with aromatase level and COX-2 expression [13].”
BackgroundResultPurohit, A., Fusi, L., Brosens, J., Woo, L. W. L., Potter, B. V. L., & Reed, M. J. (2007) · Human Reproduction · doi:10.1093/humrep/dem308 · Cited by 51
“Overall, the level of aromatase activity detected in most eutopic and ectopic samples was comparable to the reported basal levels (2–5 fmol/20 h/mg protein) in cultured endometriotic stromal cells (Velasco et al., 2006).”
BackgroundAromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review
Seal, S. L., Kamilya, G., Mukherji, J., De, A., Ghosh, D., & Majhi, A. K. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.05.021 · Cited by 52
Endometriotic Implants Regress in Rat Models Treated With Puerarin by Decreasing Estradiol Level
Chen, Y., Chen, C., Shi, S., Han, J., Wang, J., Hu, J., Liu, Y., Cai, Z., & Yu, C. (2011) · Reproductive Sciences · doi:10.1177/1933719111398500 · Cited by 47
The therapeutic significance of aromatase inhibitors in endometrial carcinoma
Gao, C., Wang, Y., Tian, W., Zhu, Y., & Xue, F. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.060 · Cited by 45
“Furthermore, this kind of inhibition is not regulated by the high levels of FSH and LH [43].”
BackgroundEndometriosis and Female Pelvic Pain
Han, E., & Kim, J. H. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1676103 · Cited by 47
Acién, P., Velasco, I., Gutiérrez, M., & Martínez-Beltrán, M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.188 · Cited by 42
Self-citationLiang, Y., & Yao, S. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.01.012 · Cited by 70
Role of nociceptor estrogen receptor GPR30 in a rat model of endometriosis pain
Alvarez, P., Bogen, O., & Levine, J. D. (2014) · Pain · doi:10.1016/j.pain.2014.09.035 · Cited by 37
Saito, A., Osuga, Y., Yoshino, O., Takamura, M., Hirata, T., Hirota, Y., Koga, K., Harada, M., Takemura, Y., Yano, T., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der125 · Cited by 36
Garzon, S., Laganà, A. S., Barra, F., Casarin, J., Cromi, A., Raffaelli, R., Uccella, S., Franchi, M. P., Ghezzi, F., & Ferrero, S. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1842356 · Cited by 49
Is aromatase expression in the endometrium the cause of endometriosis and related infertility?
Maia, H., Casoy, J., & Filho, J. V. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802627647 · Cited by 38
“What, then, would be the differences between the eutopic endometrium of patients with endometriosis and that of disease-free patients that could predispose the former to treatment failure and the consequent return of the condition? The answer to this question may lie in the abnormal expression of the aromatase enzyme,…”
ResultGorodkiewicz, E., Sankiewicz, A., & Laudański, P. (2014) · Open Chemistry · doi:10.2478/s11532-014-0512-8 · Cited by 37
Advances in targeting estrogen synthesis and receptors in patients with endometriosis
Clemenza, S., Vannuccini, S., Ruotolo, A., Capezzuoli, T., & Petraglia, F. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2152325 · Cited by 38
“tase has been detected in eutopic and ectopic endometrium of women with endometriosis [1,71].”
BackgroundDiagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights
Krygere, L., Jukna, P., Jarienė, K., & Drejerienė, E. (2024) · Biomedicines · doi:10.3390/biomedicines12122867 · Cited by 43
Non-invasive diagnosis of endometriosis: Immunologic and genetic markers
Mahini, S. M., Younesi, M., Mortazavi, G., Samare‐Najaf, M., Azadbakht, M. K., & Jamali, N. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.11.013 · Cited by 38
Sphingosine I Phosphate (S1P) Increased IL-6 Expression and Cell Growth in Endometriotic Cells
Yoshino, O., Yamada‐Nomoto, K., Kano, K., Ono, Y., Kobayashi, M., Ito, M., Yoneda, S., Nakashima, A., Shima, T., Onda, T., et al. (2019) · Reproductive Sciences · doi:10.1177/1933719119828112 · Cited by 33
Dysmenorrhea: Epidemiology, Causes and Current State of the Art for Treatment
Francavilla, R., Petraroli, M., Messina, G., Stanyevic, B., Bellani, A. M., Esposito, S. M., & Street, M. E. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5012274 · Cited by 54
“In addition, a defective immunological system fails to destroy these altered cells transported by retrograde menstrual flow [57].”
BackgroundEndometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis
Hatok, J., Zubor, P., Galo, S., Kirschnerova, R., Dobrota, D., Danko, J., & Racay, P. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2010.491925 · Cited by 28
“Realising that the molecular profile expression in the histopatologicaly associated tissue may be helpful in the prediction of associated diseases, a revolution in innovative clinical studies has started utilising eutopic endometrium focusing on apoptosis [16], tumour suppressor genes [17], immune alterations in dendr…”
BackgroundMousa, N. A., Crystal, P., Wolfman, W., Bedaiwy, M. A., & Casper, R. F. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31816956c3 · Cited by 26
Kiani, K., Rudzitis‐Auth, J., Scheuer, C., Movahedin, M., Lamardi, S. N. S., Ardakani, H. M., Becker, V., Moini, A., Aflatoonian, R., Ostad, S. N., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111918 · Cited by 29
Maia, H., Casoy, J., Correia, T., Freitas, L., Pimentel, K., & Athayde, C. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801890816 · Cited by 25
“the formation of endometriotic lesions [5].”
Reinecke, I., Schultze‐Mosgau, M., Nave, R., Schmitz, H., & Ploeger, B. A. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.846 · Cited by 27
Are aromatase inhibitors effective in endometriosis treatment?
Colette, S., & Donnez, J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.581226 · Cited by 27
“Indeed, from the end of the 1990s until very recently, aromatase was widely believed to be expressed at the transcriptional [20-48], protein [21,23,27,29,33,37,49-55] and activity levels [21,22,26,33,41,56-58].”
BackgroundHow can macroscopically normal peritoneum contribute to the pathogenesis of endometriosis?
Fassbender, A., Overbergh, L., Verdrengh, E., Kyama, C. M., Vodolazakaia, A., Bokor, A., Meuleman, C., Peeraer, K., Tomassetti, C., Waelkens, E., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.06.034 · Cited by 25
“38 [0–17]) 1.”
Chiappini, F., Sánchez, M., Miret, N. V., Cocca, C., Zotta, E., Ceballos, L., Pontillo, C. A., Bilotas, M. A., & Randi, A. S. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.10.056 · Cited by 24
Li, C., Zhao, H., Li, Y., Zhang, Y., Liu, H.-Y., Feng, F., & Yan, H. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-05980-5 · Cited by 23
“[32] confirmed that VEGF levels increased with the progression of endometriosis stage.”
BackgroundProteinase-activated receptors in the endometrium and endometriosis
Osuga, Y., Hirota, Y., Yoshino, O., Hirata, T., Koga, K., & Taketani, Y. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s326 · Cited by 22
“IL-6 increases aromatase activity, haptoglobin production, and hepatocyte growth factor production in endometriotic cells and/or endometriotic cells (104-107).”
BackgroundGeethadevi, A., Sharma, J. B., Roy, K. K., Sengupta, J., & Ghosh, D. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0553-0 · Cited by 20
“, 2006 [15] PE, OE [CE (n = 12), EE (n = 54), EC (n = 61)] IHC”
BackgroundSimsa, P., Mihalyi, A., Kyama, C. M., Mwenda, J. M., Fülöp, V., & D’Hooghe, T. M. (2007) · Women s Health · doi:10.2217/17455057.3.5.617 · Cited by 20
“Ovary No Present [114] Present [114] Present [114] Present [114] *RNA-based method.”
BackgroundInfluentialRole of sex hormones in modulating breast and ovarian cancer associated pain
McHann, M. C., Blanton, H. L., & Guindon, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111320 · Cited by 18
Li, Z., Liu, H., He, Z., Zhang, G., & Lang, J. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.07.018 · Cited by 17
Amanda, C. R., Asmarinah, A., Hestiantoro, A., Tulandi, T., & Febriyeni (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.07.061 · Cited by 19
Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis
Qu, J., Zhu, Y., Wu, X., Zheng, J., Hou, Z., Cui, Y., Mao, Y., & Liu, J. (2017) · Reproductive Sciences · doi:10.1177/1933719116681517 · Cited by 12
“Studies show that the P450arom is overexpressed in both eutopic and ectopic endometrium of patients with EM than in the endometrium of healthy women.(8-10) The local E2 levels in the endometrial and endometriotic tissue is higher than in the”
BackgroundChiappini, F., Ceballos, L., Olivares, C., Bastón, J. I., Miret, N., Pontillo, C., Zárate, L., Singla, J. J., Farina, M., Meresman, G., et al. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112867 · Cited by 11
Wu, C.-H., Yang, J.-G., Chang, Y., Hsu, C., & Kuo, P. (2013) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2013.10.006 · Cited by 11
“Aromatase overexpression has been confirmed in numerous reports on endometriosis in terms of the transcript level [7,37,53], protein level [8,9,54,55], as well as the enzymatic activity level [8,54].”
BackgroundSharifi, M., Nikoo, N. R., Badehnoosh, B., Shafabakhsh, R., Asemi, R., Reiter, R. J., & Asemi, Z. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154368 · Cited by 11
The latest advances in the pharmacological management of endometriosis
Hartner, G., Husslein, H., Kuessel, L., Gstoettner, M., Tiringer, D., Wenzl, R. J., & Perricos, A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2045274 · Cited by 9
“AIs, such as anastrozole and letrozole, block the aromatase reversibly in the ovaries and can effectively reduce endometriosis-associated pain [31,32].”
BackgroundEndometriosis in Menopausal Women—A New Age Is Coming? Literature Review
Dinu, M.-D., Hamoud, B. H., Amza, M., Gorecki, G.-P., Sima, R., Gică, N., & Pleș, L. (2024) · Life · doi:10.3390/life14040485 · Cited by 13
“The expression of aromatase P450 has been demonstrated in several studies in both the eutopic and ectopic endometrium of premenopausal patients with endometriosis [14].”
BackgroundXu, H., Yang, J., Wang, C. H., Guo, E., Yang, N.-Y., & Zhao, Q. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3053.2016 · Cited by 7
Racine, A.-C., Legrand, É., Lefebvre-Lacoeuille, C., Hoppé, E., Català, L., Sentilhes, L., & Descamps, P. (2010) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2010.03.005 · Cited by 10
Castro, J., Araya, G., Inostroza, P., Hidalgo, P., González-Ramos, R., Hugo Sovino, S., Boric, M. A., Fuentes, A., & Johnson, M. C. (2015) · Biological Research · doi:10.1186/s40659-015-0047-2 · Cited by 6
“In contrast, eutopic endometria from endometriosis patients exhibited high USF2 variants protein contents during this stage coincidently with the estrogenic microenvironment described in the eutopic and ectopic endometria of these patients [10, 13, 14, 30–32].”
ResultNave, R., Klein, S., Müller, A., Chang, X., & Höchel, J. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.984 · Cited by 6
Altered immune environment in peritoneal endometriotic lesions: relationship to lesion appearance
Ersoy, B., Hey‐Cunningham, A. J., Lindsay, L. A., Varol, N., & Markham, R. (2020) · F&S Science · doi:10.1016/j.xfss.2020.11.002 · Cited by 5
Aromatase Expression in Endometriosis and Its Significance
Ishikawa, H., & Shozu, M. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_11 · Cited by 3
Ball, E., Byrne, H. J., & Davis, C. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328216f642 · Cited by 4
Pasqualini, J. R., & Chetrite, G. S. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.027 · Cited by 3
Endometriosis and ovarian cancer
Brown, D., Pejovic, T. B., & Nezhat, F. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.015 · Cited by 3
Prospects of metformin in the treatment of endometriosis
Florova, M. S., Yarmolinskaya, M. I., & Всеволодович, П. В. (2017) · Journal of obstetrics and women s diseases · doi:10.17816/jowd66267-76 · Cited by 4
Shved, N. Y., Malysheva, O. V., Osinovskaya, N. S., Молотков, А. С., Tsypurdeyeva, A. A., Yarmolinskaya, M. I., & Баранов, В. С. (2019) · Journal of obstetrics and women s diseases · doi:10.17816/jowd68279-86 · Cited by 4
Shimura, K., Tarumi, Y., Fujii, M., Ogawa, K., Maeda, E., Tanaka, Y., Okimura, H., Kataoka, H., Takaoka, O., Ito, F., et al. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01089-5 · Cited by 4
Ovarian aromatase activity in endometriosis
Михайловна, Д. В., Всеволодович, П. В., Yarmolinskaya, M. I., & Timofeyeva, Y. M. (2013) · Journal of obstetrics and women s diseases · doi:10.17816/jowd62217-22 · Cited by 4
Gupta, S., Harlev, A., Agarwal, A. K., Rakhit, M., Ellis-Kahana, J., & Parikh, S. (2015) · SpringerBriefs in reproductive biology · doi:10.1007/978-3-319-18308-4_10 · Cited by 2
Management of Ovarian Endometrioma in Asymptomatic Reproductive Age Women
Bortoletto, P. E., & Pollie, M. (2021) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-021-00311-6 · Cited by 2
Monitoring and Managing Endocrine Disrupter Pesticides (EPDS) for Environmental Sustainability
Chintada, V., Veraiah, K., & Golla, N. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-97-7221-6_4 · Cited by 2
Lee, I.-H., Kim, D.-H., Noh, J. H., Koh, J. W., & Kim, Y. B. (2010) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2010.53.4.346 · Cited by 1
“Immunohistochemistry for aromatase was described - 348 - by Velasco et al.14 Briefly, tissue samples were fixed with 10% paraformaldehyde solution, paraffin-embedded, Sections that measured 4 μm thick were deparaffinized with xylene and rehydrated in graded ethanols, washed briefly in phosphate-buffered saline (PBS, 0…”
MethodInfluentialMedical and Surgical Management of Endometriosis
Zupi, E., Lazzeri, L., & Exacoustós, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-71138-6_2 · Cited by 1
Yarmolinskaya, M. I., & Молотков, А. С. (2019) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/2284026519853056 · Cited by 1
Molecular profiling of human endometrium and endometriosis
Huhtinen, K. (2010) · UTUPub (University of Turku) · Cited by 3
Ersoy, B. (2015) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 1
Pathophysiological factors and genetic association in endometriosis
Sundqvist, J. (2011) · Figshare · Cited by 1
Identifying biomarkers for non-invasive diagnosis of endometriosis
Irungu, S. (2016) · UCL Discovery (University College London) · Cited by 1
Physiopathologie de l'endométriose
Dumont, A., Collinet, P., Merlot, B., Abergel, A., Rubod, C., & Robin, G. (2017) · Time to knit · doi:10.1016/s0246-1064(17)65070-9 · Cited by 5
Endometrial maturation: the role of oestradiol and progesterone
Dassen, H. H. N. M. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111104hd · Cited by 1
Role of Aromatase Inhibitors in the Treatment of Endometriosis
Baştu, E. (2014) · The Annals of Clinical and Analytical Medicine · doi:10.4328/jcam.2782
“), gonadotropin releasing hormone (GnRH) analogues and danazol [5].”
BackgroundA case of atypical dengue haemorrhagic fever.
Sarkar, C., Bhattacharya, N., Mazumdar, D. K., Sarkar, T. J., & Dk, N. (2001) · PubMed
PPARy Expression in Eutopic and Ectopic Endometrium of Reproductive Age Women with Endometriosis
Dilmy, A. F., Natadisastra, M., & Sumapradja, K. (2016) · Indonesian Journal of Obstetrics and Gynecology · doi:10.32771/inajog.v3i4.55
Medical treatment of endometriosis: is it a choice of the physician?
Coroleucă, C. A., Comandașu, D.-E., Coroleucă, C. B., Mitran, M., & Brătilă, E. (2020) · Ginecologia ro · doi:10.26416/gine.27.1.2020.2885
Metadata
- Authors
- Velasco, I.
- Affiliations
- Universitat de Miguel Hernández d'Elx (ES)
- Corresponding author
- Velasco, I.
- ORCID
- Velasco, I.
- Venue
- Molecular Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-26
- Volume
- 12
- Issue
- 6
- Pages
- 377-381
- ISSN
- 1360-9947 (ISSN-L)
- 1460-2407
- OpenAlex
- W2164757963
- Cited by
- 108
- References
- 33
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 7 · 2017: 4 · 2016: 8 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 6
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- aromatase, endometriosis, endometriotic stromal cells, peritoneal fluid, interleukin-6, TNF-α, adipocytes, local estrogen production, aromatase inhibitors, immunomodulators, eutopic endometrium, ectopic endometrium
- MeSH terms
- Aromatase, Ascitic Fluid, Cells, Cultured, Dexamethasone, Endometriosis, Endometrium, Female, Humans, Immunohistochemistry, Menstrual Cycle, Tumor Necrosis Factor-alpha, Interleukin-6, Stromal Cells, Adipocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.